(firstQuint)Blood Detection of EGFR Mutation For Iressa Treatment.

 Patients without enough tissue for EGFR mutation detection can also have opportunity to use EGFR-TKI as first line therapy.

 Meanwhile, this study was also proposed to explore the best intervention time of anti-resistant drugs (such as AZD 9291, a T790M inhibitor) through the quantitative and dynamic analysis of EGFR sensitive and resistant mutation in plasma cf-DNA during EGFR-TKI treatment process.

.

 Blood Detection of EGFR Mutation For Iressa Treatment@highlight

This study was proposed to validate the efficacy of gefitinib as first-line therapy in advanced lung adenocarcinoma with EGFR mutation determined by plasma cf-DNA.

